ANEMIA, SICKLE CELL

Clinical trials for ANEMIA, SICKLE CELL explained in plain language.

Never miss a new study

Get alerted when new ANEMIA, SICKLE CELL trials appear

Sign up with your email to follow new studies for ANEMIA, SICKLE CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 4 Completed 2 Terminated 1

New drug aimed at making risky sickle cell transplants safer

Disease control Terminated

This study tested whether adding a drug called siplizumab to a stem cell transplant could make the procedure safer and more effective for adults with severe sickle cell disease. The main goal was to see if the drug could prevent the donor cells from being rejected (graft failure)…

Matched conditions: ANEMIA, SICKLE CELL

Phase: PHASE1, PHASE2 • Sponsor: Columbia University • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

ANEMIA, SICKLE CELL

Get alerted when new ANEMIA, SICKLE CELL trials appear

New drug aimed at making risky sickle cell transplants safer